IDH mutations are rare in primary glioblastoma patients with EGFR and PTEN alterations, but are commonly found in low grade gliomas and together with TP53 mutations in high grade gliomas that evolved from low grade gliomas (49). This evidence concerns the gene TP53 and central nervous system cancer.